U.S. Patent Disclosures
Thursday, July 28, 2011
Stem Cell Therapeutics Corp., of Calgary, Alberta, received U.S. Patent No. 7,964,563, titled "Oligodendrocyte Precursor Cell Proliferation Regulated By Prolactin," which covers the firm's use of Prolactin for multiple sclerosis.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.